BusinessAdamas to Announce Second Quarter 2017 Financial Results and Host Conference Call on August 8, 2017By Nasdaq OMXAug 1, 2017, 6:33 PM UTC
BusinessActinium Pharmaceuticals to Host Webinar Focused on Actimab-A and Recent Developments Related to CD33 Targeted AML Therapies on July 13, 2017 at 8:00 am ETBy Nasdaq OMXJul 13, 2017, 11:00 AM UTC
BusinessFDA Commissioner Scott Gottlieb to Deliver Keynote at RAPS Regulatory ConvergenceBy Nasdaq OMXJul 3, 2017, 1:00 PM UTC
BusinessAgile Therapeutics Resubmits New Drug Application (NDA) for its Transdermal Contraceptive Patch, Twirla®By Nasdaq OMXJun 27, 2017, 12:00 PM UTC
BusinessAdamas Announces Publication of ADS-5102 Phase 3 EASE LID Clinical Trial in JAMA NeurologyBy Nasdaq OMXJun 12, 2017, 8:01 PM UTC
BusinessCascadian Therapeutics’ Lead Candidate, Tucatinib, Receives Orphan Drug Designation from FDA for Treatment of Breast Cancer Patients with Brain MetastasesBy Nasdaq OMXJun 8, 2017, 12:01 PM UTC
BusinessProQR Receives Fast Track Designation from the FDA for QR-110 for Leber’s Congenital Amaurosis Type 10By Nasdaq OMXMay 31, 2017, 11:08 AM UTC
BusinessProQR Receives Fast Track Designation from the FDA for QR-110 for Leber’s Congenital Amaurosis Type 10By Nasdaq OMXMay 31, 2017, 11:08 AM UTC
